• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在t(1;19)阳性少突胶质细胞瘤中,NOTCH2既没有重排也没有突变。

NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.

作者信息

Benetkiewicz Magdalena, Idbaih Ahmed, Cousin Pierre-Yves, Boisselier Blandine, Marie Yannick, Crinière Emmanuelle, Hoang-Xuan Khê, Delattre Jean-Yves, Sanson Marc, Delattre Olivier

机构信息

INSERM, Unité 830, Paris, France.

出版信息

PLoS One. 2009;4(1):e4107. doi: 10.1371/journal.pone.0004107. Epub 2009 Jan 1.

DOI:10.1371/journal.pone.0004107
PMID:19119320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2606061/
Abstract

The combined deletion of 1p and 19q chromosomal arms is frequent in oligodendrogliomas (OD) and has recently been shown to be mediated by an unbalanced t(1;19) translocation. Recent studies of 1p/19q co-deleted OD suggest that the NOTCH2 gene is implicated in oligodendrocyte differentiation and may be involved in this rearrangement. The objective of the present study was to analyze the NOTCH2 locus either as a chromosomal translocation locus that may be altered by the 1p/19q recurrent rearrangement or as a gene that may be inactivated by a two hit process. We performed an array-CGH analysis of 15 ODs presenting 1p/19q co-deletion using a high-density oligonucleotide microarray spanning 1p and 19q pericentromeric regions with 377 bp average probe spacing. We showed that the 1p deletion extends to the centromere of chromosome 1 and includes the entire NOTCH2 gene. No internal rearrangement of this gene was observed. This strongly suggests that the t(1;19) translocation does not lead to an abnormal NOTCH2 structure. The analysis of the entire NOTCH2 coding sequence was performed in four cases and did not reveal any mutation therefore indicating that NOTCH2 does not harbor genetic characteristics of a tumor suppressor gene. Finally, the detailed analysis of chromosome 19 pericentromeric region led to the identification of two breakpoint clusters at 19p12 and 19q11-12. Interestingly, these two regions share a large stretch of homology. Together with previous observations of similarities between chromosome 1 and 19 alphoid sequences, this suggests that the t(1;19) translocation arises from complex intra and interchromosomal rearrangements.This is the first comprehensive deletion mapping by high density oligo-array of the 1p/19q co-deletion in oligodendroglioma tumors using a methodological approach superior to others previously applied. As such this paper provides clear evidence that the NOTCH2 gene is not physically rearranged by t(1;19) translocation of oligodendroglioma tumors.

摘要

1p和19q染色体臂联合缺失在少突胶质细胞瘤(OD)中很常见,最近研究表明其由不平衡的t(1;19)易位介导。最近对1p/19q共缺失的OD的研究表明,NOTCH2基因与少突胶质细胞分化有关,可能参与了这种重排。本研究的目的是分析NOTCH2基因座,它既可能是一个可能因1p/19q反复重排而改变的染色体易位基因座,也可能是一个可能因双打击过程而失活的基因。我们使用平均探针间距为377 bp、覆盖1p和19q着丝粒周围区域的高密度寡核苷酸微阵列,对15例呈现1p/19q共缺失的OD进行了阵列比较基因组杂交(array-CGH)分析。我们发现1p缺失延伸至1号染色体的着丝粒,包括整个NOTCH2基因。未观察到该基因的内部重排。这强烈表明t(1;19)易位不会导致NOTCH2结构异常。对4例病例的整个NOTCH2编码序列进行分析,未发现任何突变,因此表明NOTCH2不具有肿瘤抑制基因的遗传特征。最后,对19号染色体着丝粒周围区域的详细分析导致在19p12和19q11 - 12处鉴定出两个断点簇。有趣的是,这两个区域有大片同源性。结合先前关于1号和19号染色体α卫星序列相似性的观察结果,这表明t(1;19)易位源于复杂的染色体内和染色体间重排。这是首次使用优于先前应用的方法,通过高密度寡核苷酸阵列对少突胶质细胞瘤肿瘤中的1p/19q共缺失进行全面的缺失图谱分析。因此,本文提供了明确的证据,即少突胶质细胞瘤肿瘤的t(1;19)易位不会导致NOTCH2基因发生物理重排。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/ee085b7f0193/pone.0004107.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/197f4b7fd19d/pone.0004107.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/8e3642b8671d/pone.0004107.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/ee085b7f0193/pone.0004107.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/197f4b7fd19d/pone.0004107.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/8e3642b8671d/pone.0004107.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1303/2606061/ee085b7f0193/pone.0004107.g003.jpg

相似文献

1
NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.在t(1;19)阳性少突胶质细胞瘤中,NOTCH2既没有重排也没有突变。
PLoS One. 2009;4(1):e4107. doi: 10.1371/journal.pone.0004107. Epub 2009 Jan 1.
2
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
3
Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.基于网络的少突胶质细胞瘤分析预测了 1p/19q 共缺失区域内的新癌症基因候选物。
Acta Neuropathol Commun. 2018 Jun 11;6(1):49. doi: 10.1186/s40478-018-0544-y.
4
Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.利用 array CGH 鉴定高级别少突胶质细胞瘤中未缺失 1p/19q 的新型群体。
J Neurooncol. 2012 Sep;109(2):405-13. doi: 10.1007/s11060-012-0909-1. Epub 2012 Jul 24.
5
Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.1号染色体短臂和19号染色体状态以及p53和p16表达模式作为少突胶质细胞瘤的预后指标:一项使用荧光原位杂交的临床病理研究
Neuropathology. 2007 Feb;27(1):10-20. doi: 10.1111/j.1440-1789.2006.00735.x.
6
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.NOTCH2 缺失可正向预测人类神经胶质瘤亚组的存活率。
PLoS One. 2007 Jun 27;2(6):e576. doi: 10.1371/journal.pone.0000576.
7
Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas.综合分析确定了与少突胶质细胞瘤预后良好相关的基因。
Genes Chromosomes Cancer. 2016 Feb;55(2):169-76. doi: 10.1002/gcc.22323. Epub 2015 Nov 6.
8
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.t(1;19)(q10;p10)介导1p和19q联合缺失,并预示少突胶质细胞瘤患者预后较好。
Cancer Res. 2006 Oct 15;66(20):9852-61. doi: 10.1158/0008-5472.CAN-06-1796.
9
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.1p和19q染色体臂缺失在少突胶质细胞瘤诊断中的应用。石蜡包埋切片研究
Mod Pathol. 2001 Sep;14(9):842-53. doi: 10.1038/modpathol.3880400.
10
1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.1p/19q 共缺失纤维状星形细胞瘤:并非所有共缺失的都是少突胶质细胞瘤。
Ann Diagn Pathol. 2020 Jun;46:151519. doi: 10.1016/j.anndiagpath.2020.151519. Epub 2020 Apr 8.

引用本文的文献

1
Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status.基于磁共振波谱和1p/19q共缺失状态预测低级别少突胶质细胞瘤的间变转化
J Neurooncol. 2015 May;122(3):529-37. doi: 10.1007/s11060-015-1737-x. Epub 2015 Feb 26.
2
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas.SNP 芯片分析揭示了神经胶母细胞瘤中的新型基因组异常,包括杂合性丢失的拷贝中性缺失。
PLoS One. 2012;7(10):e45950. doi: 10.1371/journal.pone.0045950. Epub 2012 Oct 10.
3
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.

本文引用的文献

1
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.BAC阵列比较基因组杂交技术可区分相互排斥的改变,这些改变定义了胶质瘤的临床遗传亚型。
Int J Cancer. 2008 Apr 15;122(8):1778-86. doi: 10.1002/ijc.23270.
2
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.人类胶质母细胞瘤中着丝粒周围DNA甲基化模式的丧失与DNA甲基转移酶表达改变有关,并涉及干细胞区室。
Oncogene. 2008 Jan 10;27(3):358-65. doi: 10.1038/sj.onc.1210642. Epub 2007 Jul 23.
3
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.
同时存在 CIC 突变、IDH 突变和 1p/19q 缺失可将少突胶质细胞瘤与其他癌症区分开来。
J Pathol. 2012 Jan;226(1):7-16. doi: 10.1002/path.2995. Epub 2011 Nov 10.
4
Whole-genomic survey of oligodendroglial tumors: correlation between allelic imbalances and gene expression profiles.全基因组检测少突胶质细胞瘤:等位基因失衡与基因表达谱的相关性。
J Neurooncol. 2011 May;103(1):71-85. doi: 10.1007/s11060-010-0369-4. Epub 2010 Sep 5.
5
KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells.KIAA0495/PDAM 在少突胶质细胞瘤中经常下调,其 siRNA 敲低可诱导胶质瘤细胞对顺铂耐药。
Brain Pathol. 2010 Nov;20(6):1021-32. doi: 10.1111/j.1750-3639.2010.00405.x.
6
Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.1p 和 19q 改变的不同模式可识别出具有不同预后的人类神经胶质瘤亚型。
Neuro Oncol. 2010 Jul;12(7):664-78. doi: 10.1093/neuonc/nop075. Epub 2010 Feb 17.
7
Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.1p-19q 杂合性缺失诱导少突胶质细胞瘤基因表达的整体变化。
J Neurooncol. 2009 Dec;95(3):343-354. doi: 10.1007/s11060-009-9944-y. Epub 2009 Jul 12.
NOTCH2 缺失可正向预测人类神经胶质瘤亚组的存活率。
PLoS One. 2007 Jun 27;2(6):e576. doi: 10.1371/journal.pone.0000576.
4
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.t(1;19)(q10;p10)介导1p和19q联合缺失,并预示少突胶质细胞瘤患者预后较好。
Cancer Res. 2006 Oct 15;66(20):9852-61. doi: 10.1158/0008-5472.CAN-06-1796.
5
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.在五例少突胶质细胞瘤中鉴定出der(1;19)(q10;p10)提示1p和19q同时缺失的机制。
J Neuropathol Exp Neurol. 2006 Oct;65(10):988-94. doi: 10.1097/01.jnen.0000235122.98052.8f.
6
Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.人类胶质母细胞瘤中的全基因组低甲基化与特定拷贝数改变、亚甲基四氢叶酸还原酶等位基因状态及增殖增加相关。
Cancer Res. 2006 Sep 1;66(17):8469-76. doi: 10.1158/0008-5472.CAN-06-1547.
7
The DNA sequence and biological annotation of human chromosome 1.人类1号染色体的DNA序列及生物学注释。
Nature. 2006 May 18;441(7091):315-21. doi: 10.1038/nature04727.
8
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.大剂量化疗联合干细胞救援作为间变性少突胶质细胞瘤的初始治疗:长期随访
Neuro Oncol. 2006 Apr;8(2):183-8. doi: 10.1215/15228517-2005-009. Epub 2006 Mar 8.
9
Two types of chromosome 1p losses with opposite significance in gliomas.在胶质瘤中具有相反意义的两种1号染色体短臂缺失类型。
Ann Neurol. 2005 Sep;58(3):483-7. doi: 10.1002/ana.20607.
10
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.